Anzeige
Meldung des Tages: Der 9,5 Mio. € Kupferfehler des Marktes – Und solche Fehler korrigieren sich schnell

Charles River Laboratories International News

Aktie
WKN:  939391 ISIN:  US1598641074 US-Symbol:  CRL Land:  USA
148,88 €
-1,775 €
-1,18%
07:22:02 Uhr
Depot/Watchlist
Marktkapitalisierung *
8,85 Mrd. €
Streubesitz
-
KGV
19,84
Nachhaltigkeits-Score
49 %
Index-Zuordnung
S&P 500

Charles River Laboratories International News

02.03.26 - Businesswire
Charles River Laboratories to Present at TD Cowen and Barclays Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including:
01.03.26 n-tv
Opec+ erhöht Fördermenge: Ölpreis steigt um zehn Prozent - und soll weiter steigen
Nicht der Angriff auf den Iran lässt die Ölpreise steigen. Es ist vor allem die Sperrung der Straße von Hormus, die den Transport von Öl über das Meer behindert. Der Rohstoff dürfte ...
25.02.26 - Businesswire
Charles River Laboratories Provides Update on Planned Divestitures
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as ...
18.02.26 - Businesswire
Charles River Laboratories Announces Executive Appointments
Charles River Laboratories International, Inc. (NYSE: CRL) today announced two executive appointments: Glenn G. Coleman has been named the Company’s next Chief Financial ...
18.02.26 - Businesswire
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth quarter and full-year 2025 and provided guidance for 2026. For the quarter, revenue ...
21.01.26 - Businesswire
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-​quarter and full-year 2025 financial results and provide 2026 guidance on Wednesday, February 18 th , ...
20.01.26 - PR Newswire
Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL PR Newswire
12.01.26 - Businesswire
Charles River Laboratories Provides Business Updates
Charles River Laboratories International, Inc. (NYSE: CRL) today announced two planned acquisitions of K.F. (Cambodia) Ltd. and PathoQuest SAS; the addition of Dr. Namandjé N. ...
08.01.26 - Businesswire
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that James C. (Jim) Foster, Chair, President, and Chief Executive Officer (CEO), plans to retire, effective ...
01.12.25 - PR Newswire
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR ...
07.11.25 - PR Newswire
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River ...
27.10.25 - PR Newswire
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR ...
30.07.25 - wallstreetONLINE Redaktion
Aktienanalyse: Evotec-Aktie: Ist sie nach über 83 % Kursrückgang jetzt ein Kauf?
Evotec kämpft mit Millionenverlusten. Wie realistisch ist ein Comeback?Evotec-​Aktien haben seit 2021 mehr als 83 Prozent an Wert verloren (28.07.2025). Ist das Geschäftsmodell ...

Newssuche

Videos

newspaper
04.03.26 +13,80%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »